UPDATED Nov 25, 2025
Discover U.S. Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the NYSE and NASDAQ and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
RVTY | US$105.57 | 13.4% | -8.3% | US$11.4b | US$113.67 | PE51.5x | E29.3% | 0.3% | ||
STVN | US$23.75 | 13.9% | 18.5% | US$6.4b | US$28.79 | PE39.9x | E19.9% | 0.3% | ||
VERU | US$2.39 | -5.5% | -67.7% | US$37.6m | US$19.75 | PS2.3x | E34.6% | 0% | ||
INDV | US$33.09 | 2.6% | 196.0% | US$4.1b | US$36.71 | PE55.8x | E48.1% | 0% | ||
TEVA | US$24.98 | 0.5% | 50.5% | US$28.4b | US$27.90 | PE40.2x | E17.4% | 0% | ||
AMRX | US$12.44 | 7.5% | 50.8% | US$3.8b | US$13.50 | PE662.8x | E80.1% | 0% | ||
PRPH | US$0.18 | -30.3% | -76.0% | US$8.3m | n/a | PS1.6x | n/a | 0% | ||
INVA | US$21.72 | -0.7% | 13.5% | US$1.6b | US$32.25 | PE12.8x | E13.4% | 0% | ||
AZTA | US$38.10 | 29.5% | -16.7% | US$1.7b | US$39.60 | PE73.9x | E13.5% | 0% |